DSO SCIENTISTS DISCOVER ANTIBODIES TO COUNTER COVID-19

17jun20_news1_photo1 https://www.defencepioneer.sg/images/default-source/articles/community/2020/17-jun-20/17jun20_news1_photo1.jpg?sfvrsn=f7df21a3_3 https://www.defencepioneer.sg/pioneer-articles/dso-scientists-discover-antibodies-to-counter-covid-19
https://www.defencepioneer.sg/pioneer-articles/dso-scientists-discover-antibodies-to-counter-covid-19
DSO SCIENTISTS DISCOVER ANTIBODIES TO COUNTER COVID-19
17 Jun 2020 | COMMUNITY

DSO SCIENTISTS DISCOVER ANTIBODIES TO COUNTER COVID-19

//Story by TEO JING TING //Photos by COURTESY OF DSO NATIONAL LABORATORIES

Singapore could be seeing some good news soon.

Local defence research and development organisation DSO National Laboratories (DSO) unveiled on 17 Jun that it had discovered five antibodies to neutralise COVID-19's ability to infect and multiply in cells, and was preparing for clinical trials.
A DSO scientist preparing cell culture for antibodies production.
These antibodies were isolated from blood samples of recovered COVID-19 patients - assuring a high degree of patient safety and efficacy which are critical factors for clinical trials.

"Administration of an antibody obtained from a recovered individual transfers that person's immunity to the recipient, enabling any patient to better fight the infection and recover faster," explained Dr Conrad Chan, Principal Research Scientist and Laboratory Director (Applied Molecular Technology) from DSO.

"As antibodies remain in the system for close to a month, they can also be administered to prevent infection."

DSO scientists spent the last three months testing the five antibodies in the laboratory. In particular, the first two were isolated for testing within a month of receiving blood samples from the National Centre for Infectious Diseases and Singapore General Hospital.

Results showed that all five antibodies were potent in blocking infection, and effective against key mutations that have emerged in the virus during the pandemic.

Following this finding, DSO, as part of a Whole-of-Government collaborative effort involving agencies such as the Ministry of Defence, Ministry of Health and the Economic Development Board, has brought together a Singapore-based consortium comprising government agencies, research institutes and biomedical companies to quickly move the research on to clinical trials.

Upon approval from the Health Sciences Authority, human trials for the lead antibody, AOD01, will commence in the coming months. Manufacturing capabilities will also be scaled up on provision of therapeutic antibody treatment for COVID-19 patients once clinical trials have successfully been completed.
The DSO team working on the development of the COVID-19 antibody.
As antibodies remain in the human system for close to a month and can also be administered to prevent infections, Dr Chan said: "We want to give it to people before they become seriously ill, so that, ideally, we do not see anyone in the ICU...by preventing people from going into ICU, you prevent an overload of hospital resources."

DSO Chief Executive Officer Cheong Chee Hoo said that although the discovery was still in the experimental phase, it was an important milestone in Singapore's fight against COVID-19.

"With an effective treatment, people will be more assured as they can be treated immediately and can expect to make a faster recovery. This prevents our healthcare system from being overwhelmed, and normalises our daily routine as we continue to live and interact as a community."
Suggested Reading
Cover story
SISTERS IN ARMS
COMMUNITY
17 Jun 2020

One's got her feet firmly on the ground, the other's hungry for adventure – CPT Rebekah Abbott and CPT (Dr) Hannah Abbott share the joys of growing up and signing on with the military.

Cover story
FOUR WOMEN, 4 SERVICES, 19 YEARS OF SISTERHOOD
COMMUNITY
17 Jun 2020

Meet ME6 Toh Bao-En, LTC Nah Jinping, LTC Tong Wei Lynn and SLTC Tung Wanling.

Feature
NS ALLOWANCE TO INCREASE FROM 1 JULY 2025
COMMUNITY
17 Jun 2020

The increase is among a series of various measures to enhance the National Service (NS) experience and recognise servicemen’s contributions. 

Cover story
SAF TO GET NEW INFANTRY FIGHTING VEHICLE, 2 MORE SUBMARINES; BUILD UP UNMANNED CAPABILITIES
COMMUNITY
17 Jun 2020

Defence Minister Dr Ng Eng Hen highlighted the SAF’s long-term approach to building a next-generation fighting force, during the Committee of Supply debates on the defence budget. 

Feature
SAF SET TO EXPAND PULAU TEKONG TRAINING AREAS; SAFTI CITY OPEN FOR TRAINING
COMMUNITY
17 Jun 2020

Pulau Tekong will be expanded to stretch 10km, and is part of the SAF’s investments in training infrastructure for more effective and realistic training.

Combat medic learns to save lives in SAF-SCDF attachment
COMMUNITY
17 Jun 2020

LCP Chen Anhong stepped up to treat patients and provide emergency medical services during his six months with the SCDF.

Feature
MATCH MADE IN THE SAF
COMMUNITY
17 Jun 2020

MAJ Jayaram Venugobalan Naidu and Kasturibai Athmaram went from schoolmates to soulmates after a chance posting to the same unit reconnected the two.

HE STRUCK (DIVERS’) GOLD
COMMUNITY
17 Jun 2020

Inspired by his father who was a Commando NSman, 3SG Fong Zheng Wei went from failing IPPT to achieving Divers’ Gold.

TWICE THE STRENGTH, DOUBLE THE PRIDE
COMMUNITY
17 Jun 2020

3SG Irfan and 3SG Iryan Hidayat have walked almost identical paths all their lives —from attending the same schools to enlisting for NS and, now, graduating as newly minted sergeants together.  

Feature
AFTER “EVER AFTER”
COMMUNITY
17 Jun 2020

From best friends to lovers, and now parents of two (with a third on the way!): Army couple CPT Nuraishah and 3WO Shahibul share how their love is still going strong.